New Haven pharmaceutical company Alexion to lay off more than 200 employees
The New Haven Register reports that a spokeswoman for Alexion Pharmaceuticals said Monday that the 210 layoffs represent about 7 percent of Alexion’s 3,000-person workforce.
The biopharmaceutical company, which makes drugs to treat rare diseases, says the move aims to help position the company for “sustainable, long-term growth.” It’s unclear where the layoffs are being made.
Officials with the state Department of Economic and Community Development weren’t immediately available for comment Tuesday.
Alexion has a manufacturing facility in Smithfield, Rhode Island.
In December, Ridgefield-based Boehringer Ingelheim notified 180 local employees that they will be laid off.